These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2420298)

  • 21. Single-dose captopril administration in DOCA/salt rats: reduction of hypotensive effect by indomethacin.
    Miyamori I; Brown MJ; Dollery CT
    Clin Exp Hypertens (1978); 1980; 2(6):935-45. PubMed ID: 7004806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of captopril on the renal hemodynamics during aprotinin infusion in anesthetized dogs.
    Mizumura Y; Matsumoto M; Nishino A; Takata M; Iida H; Sugimoto T
    Ren Physiol; 1984; 7(5):299-303. PubMed ID: 6207570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered blood pressure and renin responses to converting enzyme inhibition after aprotinin-induced kallikrein-kinin-system blockade.
    Overlack A; Stumpe KO; Kühnert M; Heck I
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():129s-132s. PubMed ID: 6160938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of hypotensive mechanisms of captopril in addition to its inhibition of the converting enzyme in spontaneously hypertensive rats.
    Mikami H; Ogihara T; Ohde H; Naka T; Kumahara Y
    Jpn Circ J; 1982 Nov; 46(11):1154-8. PubMed ID: 6182310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of aprotinin (a serine protease inhibitor) on renal function and renin release.
    Seto S; Kher V; Scicli AG; Beierwaltes WH; Carretero OA
    Hypertension; 1983; 5(6):893-9. PubMed ID: 6197374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
    McCaa RE; Gillespie JB
    Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of an orally active converting enzyme inhibitor (YS-980) on renal function in dogs.
    Abe Y; Miura K; Imanishi M; Yukimura T; Komori T; Okahara T; Yamamoto K
    J Pharmacol Exp Ther; 1980 Jul; 214(1):166-70. PubMed ID: 6156237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of effect of indomethacin and captopril on protein-induced glomerular hyperfiltration in normal subjects.
    Uemasu J; Maeda N; Suyama A; Kawasaki H; Hirayama C
    Nihon Jinzo Gakkai Shi; 1989 Feb; 31(2):179-83. PubMed ID: 2661888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of the mechanism of acute decrease of blood pressure induced by captopril (SQ 14,225) in dogs by the use of aprotinin, SAR1-ILE8-angiotensin II and indomethacin.
    Ohara N; Ono H; Hashimoto K
    Jpn Circ J; 1981 Jun; 45(6):672-9. PubMed ID: 6165844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study of renovascular hypertension in rats. III. Effects of converting enzyme inhibitor (captopril) on the plasma and renal renin activity in two-kidney goldblatt hypertension in rats.
    Matsushita K
    Tokai J Exp Clin Med; 1985 Oct; 10(5):545-9. PubMed ID: 3915608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute hypotensive effect of captopril in man modified by prostaglandin synthesis inhibition.
    Silberbauer K; Stanek B; Templ H
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):87S-93S. PubMed ID: 6753910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of renal prostaglandins in sympathetically mediated renin relase in the rat.
    Campbell WB; Graham RM; Jackson EK
    J Clin Invest; 1979 Aug; 64(2):448-56. PubMed ID: 37256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels.
    Lechi A; Covi G; Capuzzo MG; Lechi C; Minuz P; Delva P; Scuro LA
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular effects of centrally administered arachidonic acid in haemorrhage-induced hypotensive rats: investigation of a peripheral mechanism.
    Yalcin M; Aydin C
    Clin Exp Pharmacol Physiol; 2009 Apr; 36(4):447-53. PubMed ID: 19702598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal PGE2 release may not be responsible for captopril-induced renal effects in anesthetized dogs.
    Satoh S; Hayashi M; Suzuki M; Hisa H; Kamijo T
    J Cardiovasc Pharmacol; 1982; 4(6):960-5. PubMed ID: 6185789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of converting-enzyme inhibition on cardiorenal hemodynamics in patients with chronic congestive heart failure.
    Kubo S; Nishioka A; Nishimura H; Kawamura K; Takatsu T
    J Cardiovasc Pharmacol; 1985; 7(4):753-9. PubMed ID: 2410718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of captopril on blood pressure responses to enkephalins in chloralose-anaesthetized rats.
    Geh SL; Nott MW; Majewski H; Rand MJ
    Arch Int Pharmacodyn Ther; 1986 Feb; 279(2):282-90. PubMed ID: 3516093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of adrenergic nervous and prostaglandin systems on hydralazine-induced renin release.
    Sinaiko AR
    Life Sci; 1983 Dec; 33(23):2269-75. PubMed ID: 6316059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The mechanism of the hypotensive effect of captopril (converting enzyme inhibitor) with special reference to the kallikrein-kinin and renin-angiotensin systems.
    Iimura O; Shimamoto K; Tanaka S; Hosoda S; Nishitani T; Ando T; Masuda A
    Jpn J Med; 1986 Feb; 25(1):34-9. PubMed ID: 3520064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The kallikrein-kinin system in blood pressure homeostasis.
    Lee TC; Kushiro T; Gassia JP; Girolami JP; Lupu AN; Maxwell MH
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():255s-258s. PubMed ID: 94277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.